Development of a pharmacokinetic/pharmacodynamic (PK/PD)-simulation system for doxorubicin in long circulating liposomes in mice using peritoneal P388

Journal of Controlled Release

Volumn 61, Issue 1-2, 1999, Pages 9-19

  Tsuchihashi, Mari ^a   Harashima, Hideyoshi ^a   Kiwada, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Drug delivery system; Pharmacodynamics; Pharmacokinetics; Simulation

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; LIPOSOME;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; ENCAPSULATION; LEUKEMIA P 388; MOUSE; NONHUMAN; PERITONEUM TUMOR; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; SIMULATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG CARRIERS; LEUKEMIA P388; LIPOSOMES; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED DBA; PERITONEAL NEOPLASMS;

EID: 0032875094     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00103-0     Document Type: Article

References (26)

1. Woodle M.C. Sterically stabilized liposome therapeutics. Adv. Drug Deliv. Rev. 16:1995;249-265.
2. Harashima H., Kiwada H. Liposomal targeting and drug delivery: Kinetic consideration. Adv. Drug Deliv. Rev. 19:1996;425-444.
3. M.A. Fischl, S.E. Krown, K.P. O'Boyle, R. Mitsuyasu, S. Miles, J.C. Wernz, P.A.Volberding, J. Kahn, J.E. Groopman, J. Feinberg, M. Woody, The AIDS Clinical Trials Group, Weekly doxorubicin in the treatment of patients with AIDS- related Kaposi's sarcoma, J. Acquir. Immune Defic. Syndr. 6 (1993) 259-264.
4. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.-D., Woodle M.C., Lasic D.D., Redemann C., Martin F.J. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA. 88:1991;11460-11464.
5. Vaage J., Mayhew E., Lasic D., Martin F. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int. J. Cancer. 51:1992;942-948.
6. Gabizon A.A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 52:1992;891-896.
7. Urakami Y., Harashima H., lida S., Nagayasu A., Kiwada H. Kinetic study on the optimization of tumor delivery of antitumor agents by liposomes: Simulation study based on the physiological modeling. Drug Deliv. Syst. 12:1997;403-408.
8. Bally M.B., Masin D., Nayar R., Cullis P.R., Mayer L.D. Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice. Cancer Chemother. Pharmacol. 34:1994;137-146.
9. Harashima H., Yamane C., Kume Y., Kiwada H. Kinetic analysis of AUC-dependent saturable clearance of liposomes: Mathematical description of AUC-dependency. J. Pharmacokinet. Biopharm. 21:1993;299-308.
10. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., K Huang S., Lee K.-D., Woodle M.C., Lasic D.D., Redemann C., Martin F.J. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA. 88:1991;11460-11464.
11. Huang S.K., Lee K.-D., Hong K., Friend D.S., Papahadjopoulos D. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 52:1992;5135-5143.
12. Ozawa S., Sugiyama Y., Mitsuhashi Y., Kobayashi T., Inaba M. Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time product. Cancer Chemother. Pharmacol. 21:1988;185-190.
13. H. Harashima, S. Iida, Y. Urakami, M. Tsuchihashi, H. Kiwada, Optimization of antitumor effect of liposomaly encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling, J. Control. Release, in press.
14. Mayer L.D., Tai L.C.L., Bally M.B., Mitilenes G.N., Ginsberg R.S., Cullis P.R. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta. 1025:1990;143-151.
15. Yamaoka K., Nakagawa T.A. Nonlinear least squares program based on differential equations MULTI(RUNGE) for microcomputers. J. Pharmacobiodyn. 6:1983;595-606.
16. Flessner M.F., Dedrick R.L., Schultz J.S. Exchange of macromolecules between peritoneal cavity and plasma. Am. J. Physiol. 248:1984;H15-H25.
17. Gabizon A., Shiota R., Papahadojopoulos D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J. Natl. Cancer Inst. 81:1989;1484-1488.
18. Mayhew E., Cimino M., Klemperer J., Lazo R., Wiernikowski J., Arbuck S. Free and liposomal doxorubicin treatment of intraperitoneal colon 26 tumor: Therapeutic and pharmacologic studies. Selective Cancer Therapeutic. 6:1990;193-209.
19. Inaba M., Johnson R.K. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant subline of P388 leukemia. Biochem. Pharmacol. 27:1978;2123-2130.
20. Harasym T.O., Cullis P.R., Bally M.B. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes. Cancer Chemother. Pharmacol. 40:1997;309-317.
21. Nagy J.A., Herzberg K.T., Masse E.M., Zientara G.P., Dvorak H.F. Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. Cancer Res. 49:1989;5448-5458.
22. Leypoldt J.K., Parker H.R., Frigon R.P., Henderson L.W. Molecular size dependence of peritoneal transport. J. Lab. Clin. Med. 110:1987;207-216.
23. Uchiyama K., Nagayasu A., Yamagiwa Y., Nishida T., Harashima H., Kiwada H. Effect of liposomal fluidity and size on its tumor accumulation: A presumption of interaction between liposomes and solid tumor. Int. J. Pharm. 121:1995;195-203.
24. 14C]adriamycin following intraperitoneal administration to rats. Cancer Res. 41:1981;1311-1317.
25. Park J.W., Hong K., Carter P., Asgari H., Guo L.Y., Keller G.A., Wirth C., Shalaby R., Kotts C., Wood W.I., Papahadjopoulos D., Benz C.C. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA. 92:1995;1327-1331.
26. Forssen E.A., Male-Brune R., Adler-Moore J.P., Lee M.J.A., Schmidt P.J., Krasieva T.B., Shimizu S., Tromberg B.J. Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue. Cancer Res. 56:1996;2066-2075.